Works by Otsuka, Tomoyuki


Results: 38
    1
    2
    3

    Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study.

    Published in:
    PLoS ONE, 2022, v. 17, n. 11, p. 1, doi. 10.1371/journal.pone.0275865
    By:
    • Nishikawa, Tatsuya;
    • Inoue, Takako;
    • Otsuka, Tomoyuki;
    • Kuno, Ikumi;
    • Kukita, Yoji;
    • Nakamura, Harumi;
    • Ikeda, Yoshihiko;
    • Yasui, Taku;
    • Shioyama, Wataru;
    • Oka, Toru;
    • Honma, Keiichirou;
    • Hatakeyama, Kinta;
    • Miyata, Hiroshi;
    • Isei, Taiki;
    • Ishihara, Ryu;
    • Kumagai, Toru;
    • Nishimura, Kazuo;
    • Fujita, Masashi
    Publication type:
    Article
    4
    5
    6

    Sparsentan is superior to losartan in the gddY mouse model of IgA nephropathy.

    Published in:
    Nephrology Dialysis Transplantation, 2024, v. 39, n. 9, p. 1494, doi. 10.1093/ndt/gfae021
    By:
    • Nagasawa, Hajime;
    • Ueda, Seiji;
    • Suzuki, Hitoshi;
    • Jenkinson, Celia;
    • Fukao, Yusuke;
    • Nakayama, Maiko;
    • Otsuka, Tomoyuki;
    • Okuma, Teruyuki;
    • Clapper, Wilmelenne;
    • Liu, Kai;
    • Nguyen, Mai;
    • Komers, Radko;
    • Suzuki, Yusuke
    Publication type:
    Article
    7
    8
    9
    10
    11
    12

    Randomized Phase II trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-maintenance therapy in previously untreated advanced non-small cell lung cancer

    Published in:
    BMC Research Notes, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-0500-6-3
    By:
    • Minami, Seigo;
    • Kijima, Takashi;
    • Shiroyama, Takayuki;
    • Okafuji, Kohei;
    • Hirashima, Tomonori;
    • Uchida, Junji;
    • Imamura, Fumio;
    • Osaki, Tadashi;
    • Nakatani, Takeshi;
    • Ogata, Yoshitaka;
    • Yamamoto, Suguru;
    • Namba, Yoshinobu;
    • Otsuka, Tomoyuki;
    • Tachibana, Isao;
    • Komuta, Kiyoshi;
    • Kawase, Ichiro
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    A phase II study of the safety of olanzapine for oxaliplatin based chemotherapy in coloraectal patients.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84225-6
    By:
    • Nishimura, Junichi;
    • Hasegawa, Akiko;
    • Kudo, Toshihiro;
    • Otsuka, Tomoyuki;
    • Yasui, Masayoshi;
    • Matsuda, Chu;
    • Haraguchi, Naotsugu;
    • Ushigome, Hajime;
    • Nakai, Nozomu;
    • Abe, Tomoki;
    • Hara, Hisashi;
    • Shinno, Naoki;
    • Asukai, Kei;
    • Hasegawa, Shinichiro;
    • Yamada, Daisaku;
    • Sugimura, Keijiro;
    • Yamamoto, Kazuyoshi;
    • Wada, Hiroshi;
    • Takahashi, Hidenori;
    • Omori, Takeshi
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Classification of idiopathic interstitial pneumonias using anti-myxovirus resistance-protein 1 autoantibody.

    Published in:
    Scientific Reports, 2017, p. 43201, doi. 10.1038/srep43201
    By:
    • Hamano, Yoshimasa;
    • Kida, Hiroshi;
    • Ihara, Shoichi;
    • Murakami, Akihiro;
    • Yanagawa, Masahiro;
    • Ueda, Ken;
    • Honda, Osamu;
    • Tripathi, Lokesh P.;
    • Arai, Toru;
    • Hirose, Masaki;
    • Hamasaki, Toshimitsu;
    • Yano, Yukihiro;
    • Kimura, Tetsuya;
    • Kato, Yasuhiro;
    • Takamatsu, Hyota;
    • Otsuka, Tomoyuki;
    • Minami, Toshiyuki;
    • Hirata, Haruhiko;
    • Inoue, Koji;
    • Nagatomo, Izumi
    Publication type:
    Article
    37
    38